Which of the following is NOT an indication for administering Fresh Frozen Plasma?

Fresh Frozen Plasma (FFP) is a component of blood that is rich in clotting factors and is primarily used to treat patients with coagulopathies or deficiencies in clotting factors. The indications for administering FFP primarily relate to conditions where there is a need to restore the balance of clotting factors in the blood, such as in liver failure, disseminated intravascular coagulation (DIC), and scenarios involving massive red blood cell transfusion.

Liver failure is a clear indication for FFP administration because the liver is responsible for producing many of the clotting factors necessary for normal coagulation. When the liver fails, there is a critical depletion of these factors, and FFP can help restore them.

In the case of DIC, a complex disorder characterized by the widespread activation of the clotting cascade, the administration of FFP can help provide needed clotting factors as the patients can experience various bleeding complications due to the consumption of clotting factors.

Massive red blood cell transfusions can lead to dilutional coagulopathy, where the transfusion of red cells dilutes the coagulation factors present in the blood. FFP is used in this context to replenish these factors and improve coagulation.

Heart failure, on the other